BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34687993)

  • 1. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
    Alter BP; Best AF
    Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
    Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
    Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Molecular Characterization of Fanconi Anemia Patients in Turkey.
    Toksoy G; Uludağ Alkaya D; Bagirova G; Avcı Ş; Aghayev A; Günes N; Altunoğlu U; Alanay Y; Başaran S; Berkay EG; Karaman B; Celkan TT; Apak H; Kayserili H; Tüysüz B; Uyguner ZO
    Mol Syndromol; 2020 Nov; 11(4):183-196. PubMed ID: 33224012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PALB2/FANCN: recombining cancer and Fanconi anemia.
    Tischkowitz M; Xia B
    Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.
    Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
    Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
    Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.
    Miele E; Mastronuzzi A; Po A; Carai A; Alfano V; Serra A; Colafati GS; Strocchio L; Antonelli M; Buttarelli FR; Zani M; Ferraro S; Buffone A; Vacca A; Screpanti I; Giangaspero F; Giannini G; Locatelli F; Ferretti E
    Biomark Res; 2015; 3():13. PubMed ID: 26064523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
    Doss CG; Nagasundaram N
    Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fanconi anemia and solid malignancies in childhood: a national retrospective study.
    Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F
    Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
    Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
    Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anaemia and cancer: an intricate relationship.
    Nalepa G; Clapp DW
    Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics.
    Bakker JL; Thirthagiri E; van Mil SE; Adank MA; Ikeda H; Verheul HM; Meijers-Heijboer H; de Winter JP; Sharan SK; Waisfisz Q
    Hum Mutat; 2014 Apr; 35(4):442-6. PubMed ID: 24395671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.